Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
22:10:54 EST Fri 23 Jan 2026
Enter Symbol
or Name
USA
CA



Q:TEM - TEMPUS AI INC - https://investors.tempus.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TEM - Q0.165.59·65.666.465.32-3.04-4.43,927.6256,44449,46368.81  68.95  64.84104.32  36.2219:59:18Jan 2115 min RT 2¢

Recent Trades - Last 10 of 49463
Time ETExPriceChangeVolume
19:59:18Q65.88-2.481
19:59:15Q65.59-2.77100
19:59:10Q65.59-2.7754
19:58:57Q65.60-2.7676
19:58:41Q65.65-2.7150
19:58:41Q65.61-2.7510
19:58:40Q65.68-2.6830
19:58:12Q65.61-2.759
19:57:02Q65.73-2.631
19:56:50Q65.68-2.68150

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-21 08:30U:TEMNews ReleaseTempus Announces the Launch of Paige Predict
2026-01-12 08:30U:TEMNews ReleaseTempus and NYU Langone Health Announce Strategic Collaboration to Advance Precision Oncology
2026-01-12 07:00U:TEMNews ReleaseNorthwestern Medicine Selects Tempus to Expand Genomic Testing
2026-01-11 17:30U:TEMNews ReleaseTempus Achieves Record Total Contract Value Exceeding $1.1 Billion
2026-01-11 17:00U:TEMNews ReleaseTempus Announces Preliminary Fourth Quarter and Full Year 2025 Results
2026-01-08 08:30U:TEMNews ReleaseTempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO(TM) Gastrointestinal Cancers Symposium
2026-01-06 08:30U:TEMNews ReleaseTempus to Present at 44th Annual J.P. Morgan Healthcare Conference
2025-12-09 08:30U:TEMNews ReleaseTempus Announces Ten Abstracts Accepted for Presentation at the 2025 San Antonio Breast Cancer Symposium
2025-11-18 08:30U:TEMNews ReleaseTempus to Participate in the Piper Sandler 37th Annual Healthcare Conference
2025-11-14 08:30U:TEMNews ReleaseTempus and IFLI Announce Study to Advance Follicular Lymphoma Research
2025-11-05 08:30U:TEMNews ReleaseTempus Announces Six Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer Annual Meeting 2025
2025-11-04 16:01U:TEMNews ReleaseTempus Reports Third Quarter 2025 Results
2025-10-28 08:30U:TEMNews ReleaseTempus to Participate in the Stifel 2025 Healthcare Conference
2025-10-21 08:30U:TEMNews ReleaseTempus to Report Third Quarter 2025 Financial Results on November 4
2025-10-20 09:00U:TEMNews ReleaseAmbry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity
2025-10-16 08:30U:TEMNews ReleaseTempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research
2025-10-15 08:30U:TEMNews ReleaseTempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025
2025-10-09 08:30U:TEMNews ReleaseTempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy
2025-10-01 12:24U:TEMNews ReleaseAmbry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density
2025-09-22 08:30U:TEMNews ReleaseTempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device